Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01408823 · ClinicalTrials.gov registry record
Pharmacokinetics of Aminocaproic Acid in Scoliosis Surgery
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 20
- Enrollment target
NCT01408823: Completed study, sponsored by Children's Hospital of Philadelphia.
NCT01408823 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01408823 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This study will evaluate the pharmacokinetics of antifibrinolytic drug epsilon-aminocaproic acid (EACA) in children undergoing Posterior spinal fusion surgery (PSF) at The Children's Hospital of Philadelphia (CHOP) who receive EACA at the standard dose reported in the literature for this population and currently in use at CHOP.
Primary Outcome
The primary endpoint is the clearance of EACA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-07 |
| Est. Completion | 2011-10 |
What the finished NCT01408823 record still lists
NCT01408823 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01408823 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01408823 about?
NCT01408823 is a clinical study titled "Pharmacokinetics of Aminocaproic Acid in Scoliosis Surgery". This study will evaluate the pharmacokinetics of antifibrinolytic drug epsilon-aminocaproic acid (EACA) in children undergoing Posterior spinal fusion surgery (PSF) at The Children's Hospital of Philadelphia (CHOP) who receive EACA at the standard dose reported in the literature for this population ...
What is the current status of trial NCT01408823?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2011-07. Estimated completion is 2011-10.
Who is sponsoring clinical trial NCT01408823?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia